Breyer MD - Search Results

1

The next generation of therapeutics for chronic kidney disease.

Breyer MD, Susztak K. Breyer MD, et al. Nat Rev Drug Discov. 2016 Aug;15(8):568-88. doi: 10.1038/nrd.2016.67. Epub 2016 May 27. Nat Rev Drug Discov. 2016. PMID: 27230798 Free PMC article. Review.

2

Developing Treatments for Chronic Kidney Disease in the 21st Century.

Breyer MD, Susztak K. Breyer MD, et al. Semin Nephrol. 2016 Nov;36(6):436-447. doi: 10.1016/j.semnephrol.2016.08.001. Semin Nephrol. 2016. PMID: 27987541 Free PMC article. Review.

3

Diabetic nephropathy: a national dialogue.

Breyer MD, Coffman TM, Flessner MF, Fried LF, Harris RC, Ketchum CJ, Kretzler M, Nelson RG, Sedor JR, Susztak K; Kidney Research National Dialogue (KRND). Breyer MD, et al. Clin J Am Soc Nephrol. 2013 Sep;8(9):1603-5. doi: 10.2215/CJN.03640413. Epub 2013 Jun 20. Clin J Am Soc Nephrol. 2013. PMID: 23788618 Free PMC article.

4

Novel avenues for drug discovery in diabetic kidney disease.

Breyer MD, Kretzler M. Breyer MD, et al. Expert Opin Drug Discov. 2018 Jan;13(1):65-74. doi: 10.1080/17460441.2018.1398731. Epub 2017 Nov 16. Expert Opin Drug Discov. 2018. PMID: 29145743 Review.

5

A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease.

Agarwal R, Duffin KL, Laska DA, Voelker JR, Breyer MD, Mitchell PG. Agarwal R, et al. Among authors: breyer md. Nephrol Dial Transplant. 2014 Dec;29(12):2293-302. doi: 10.1093/ndt/gfu255. Epub 2014 Aug 1. Nephrol Dial Transplant. 2014. PMID: 25085239

6

Mouse models of diabetic nephropathy.

Brosius FC 3rd, Alpers CE, Bottinger EP, Breyer MD, Coffman TM, Gurley SB, Harris RC, Kakoki M, Kretzler M, Leiter EH, Levi M, McIndoe RA, Sharma K, Smithies O, Susztak K, Takahashi N, Takahashi T; Animal Models of Diabetic Complications Consortium. Brosius FC 3rd, et al. Among authors: breyer md. J Am Soc Nephrol. 2009 Dec;20(12):2503-12. doi: 10.1681/ASN.2009070721. Epub 2009 Sep 3. J Am Soc Nephrol. 2009. PMID: 19729434 Free PMC article. Review.

7

Role of TGF-alpha in the progression of diabetic kidney disease.

Heuer JG, Harlan SM, Yang DD, Jaqua DL, Boyles JS, Wilson JM, Heinz-Taheny KM, Sullivan JM, Wei T, Qian HR, Witcher DR, Breyer MD. Heuer JG, et al. Among authors: breyer md. Am J Physiol Renal Physiol. 2017 Jun 1;312(6):F951-F962. doi: 10.1152/ajprenal.00443.2016. Epub 2017 Mar 1. Am J Physiol Renal Physiol. 2017. PMID: 28249836 Free article.

8

Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study.

Cid Ruzafa J, Paczkowski R, Boye KS, Di Tanna GL, Sheetz MJ, Donaldson R, Breyer MD, Neasham D, Voelker JR. Cid Ruzafa J, et al. Among authors: breyer md. Int J Clin Pract. 2015 Aug;69(8):871-82. doi: 10.1111/ijcp.12640. Epub 2015 May 25. Int J Clin Pract. 2015. PMID: 26011029

9

The Use of Genomics to Drive Kidney Disease Drug Discovery and Development.

Reilly DF, Breyer MD. Reilly DF, et al. Among authors: breyer md. Clin J Am Soc Nephrol. 2020 Sep 7;15(9):1342-1351. doi: 10.2215/CJN.11070919. Epub 2020 Mar 19. Clin J Am Soc Nephrol. 2020. PMID: 32193173 Free PMC article. Review.

10

Nonselective Cyclooxygenase Inhibition Retards Cyst Progression in a Murine Model of Autosomal Dominant Polycystic Kidney Disease.

Zhang M, Srichai MB, Zhao M, Chen J, Davis LS, Wu G, Breyer MD, Hao CM. Zhang M, et al. Among authors: breyer md. Int J Med Sci. 2019 Jan 1;16(1):180-188. doi: 10.7150/ijms.27719. eCollection 2019. Int J Med Sci. 2019. PMID: 30662341 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

215 results

Search Page